• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Changes of plasma atrial and brain natriuretic peptide levels during hemodialysis.

作者信息

Ishikura F, Ando Y, Park Y D, Tani A, Shirai D, Matsuoka H, Miyatake K

机构信息

Department of Medicine, Osaka Kosei-Nenkin Hospital, Japan.

出版信息

Ren Fail. 1996 Mar;18(2):261-70. doi: 10.3109/08860229609052796.

DOI:10.3109/08860229609052796
PMID:8723364
Abstract

OBJECTIVES

The purpose of this study was to evaluate the effect of hemodialysis on the plasma concentration of atrial and brain natriuretic peptides, and to determine the two-dimensional echocardiographic parameters affecting the changes of plasma atrial and brain natriuretic peptide levels in patients with chronic renal failure.

BACKGROUND

Brain natriuretic peptide has been found in human cardiac tissue and increases in patients with congestive heart failure. However, the factors that stimulate the secretion of plasma brain natriuretic peptide have not yet been fully clarified.

METHODS

In 15 patients with chronic renal failure, plasma atrial and brain natriuretic peptide levels and two-dimensional echocardiographic parameters were measured before and after each session of hemodialysis.

RESULTS

Plasma atrial natriuretic peptide levels significantly decreased from 367 +/- 537 pg/mL to 138 +/- 167 pg/mL after hemodialysis (p < 0.01). However, plasma brain natriuretic peptide levels did not significantly change after hemodialysis. Left atrial dimension significantly decreased (41.1 +/- 6.6 vs. 36.3 +/- 6.2 mm, p < 0.01) and left ventricular end-diastolic dimension slightly decreased after hemodialysis (57.0 +/- 10.3 vs. 55.7 +/- 9.9 mm, p < 0.05). The decrease of left atrial dimension was greater than that of left ventricular end-diastolic dimension (4.9 +/- 1.6 vs. 1.3 +/- 0.6 mm, p < 0.05). Plasma brain natriuretic peptide levels significantly correlated with fractional shortening both before and after hemodialysis (r = 0.65, p < 0.05).

CONCLUSION

Plasma atrial natriuretic peptide levels significantly decreased as the right and left atrial overloads decreased, and plasma brain natriuretic peptide levels did not significantly decrease after hemodialysis. Plasma brain natriuretic peptide levels were not significantly influenced by acute hemodynamic change, such as hemodialysis. However, plasma brain natriuretic peptide levels were significantly correlated with basic cardiac function.

摘要

相似文献

1
Changes of plasma atrial and brain natriuretic peptide levels during hemodialysis.
Ren Fail. 1996 Mar;18(2):261-70. doi: 10.3109/08860229609052796.
2
Usefulness of long axis M-mode echocardiographic measurements for optimum dialysis in patients on maintenance hemodialysis: comparison with changes in plasma levels of atrial natriuretic peptide and brain natriuretic peptide.长轴M型超声心动图测量对维持性血液透析患者优化透析的有用性:与心房利钠肽和脑利钠肽血浆水平变化的比较
Clin Nephrol. 2001 Aug;56(2):140-9.
3
Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.慢性肾衰竭患者血液透析期间脑钠肽和心房钠尿肽血浆浓度的变化
Horm Metab Res. 1994 May;26(5):246-9. doi: 10.1055/s-2007-1001675.
4
Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.依赖透析的慢性肾衰竭患者及左心室充盈压升高患者血浆中脑钠肽和心房钠尿肽浓度增加。
Clin Investig. 1994 Jun;72(6):430-4. doi: 10.1007/BF00180516.
5
Atrial and brain natriuretic peptides in cardiovascular diseases.心血管疾病中的心房利钠肽和脑利钠肽
Hypertension. 1994 Jan;23(1 Suppl):I231-4. doi: 10.1161/01.hyp.23.1_suppl.i231.
6
Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.收缩性心力衰竭中的舒张功能障碍与利钠肽。较高的心房利钠肽(ANP)和脑钠肽(BNP)水平与限制性充盈模式相关。
Eur Heart J. 1996 Nov;17(11):1694-702. doi: 10.1093/oxfordjournals.eurheartj.a014753.
7
Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients.血液透析患者中脑钠肽和心房利钠肽的差异调节
Clin Nephrol. 1993 Aug;40(2):83-90.
8
Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis.通过竞争和非竞争免疫测定法测定的心脏利钠肽在慢性血液透析肾衰竭患者中的临床相关性。
J Endocrinol Invest. 2001 Jan;24(1):24-30. doi: 10.1007/BF03343804.
9
Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.终末期肾病患者循环利钠肽浓度:脑利钠肽作为心室重塑生物标志物的作用
Mayo Clin Proc. 2001 Nov;76(11):1111-9. doi: 10.4065/76.11.1111.
10
[Value of plasma brain natriuretic peptide detection in cardiac function assessment in hemodialysis patients].[血浆脑钠肽检测在血液透析患者心功能评估中的价值]
Di Yi Jun Yi Da Xue Xue Bao. 2005 Jul;25(7):892-4.